Frank Kloprogge

16PUBLICATIONS
51CO-AUTHORS
PharmacogenomicsEpidemiological modellingReaction engineering (excl. nuclear reactions)ChemotherapyAdversarial machine learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 10, 2026
Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatment.

|Jun 10, 2026
Pharmacokinetic-pharmacodynamic modeling using combined time-kill data for meropenem and colistin or polymyxin B combination effects in Acinetobacter baumannii.

|Mar 31, 2026
Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients.

Bern-Thomas Nyang'wa, Ilaria Motta, Ronelle Moodliar

|Oct 24, 2025
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.

Marie Wijk, Paolo Denti, Kamunkhwala Gausi

|Nov 04, 2024
Personalized CZA-ATM dosing against an XDR E. coli in liver transplant patients; the application of the in vitro hollow fiber system.

Zahra Sadouki, Emmanuel Q Wey, Satheesh Iype

|Oct 08, 2024
Named entity recognition of pharmacokinetic parameters in the scientific literature.

Ferran Gonzalez Hernandez, Quang Nguyen, Victoria C Smith

Pageof 3

Frequent Collaborators

3 joint publications

Paolo Denti

3 joint publications

Bern-Thomas Nyang'wa

2 joint publications

C Robert Horsburgh

2 joint publications

Marie Wijk